Ning Wan
Post Doctoral Research Station
Guangzhou, 510010, China
Guangzhou, 510010, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Taxanes Versus Pemetrexed After Osimertinib Resistance in EGFR-Mutated NSCLC: A Retrospective Cohort with Two-Model In Vitro Validation.
Journal: Cancer management and research
Published: September 03, 2025
TTF-1 expression stratifies chemoimmunotherapy benefits in PD-L1-negative lung adenocarcinoma: a real-world biomarker validation.
Journal: Journal of thoracic disease
Published: March 26, 2025
Unveiling Doping Kinetics in Cu(I) Metal Halides for Customized Luminescent Performance.
Journal: The journal of physical chemistry letters
Published: January 21, 2025
Real-world Study of the Safety and Efficacy of Pembrolizumab in the Treatment of Advanced Non-small Cell Lung Cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: December 04, 2024
Cost-effectiveness analysis of pembrolizumab versus chemotherapy in advanced non-small cell lung cancer in China based on real-world studies.
Journal: Journal of cancer research and clinical oncology
Published: May 09, 2024
Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: September 14, 2022
Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment.
Journal: Frontiers in pharmacology
Published: April 07, 2022
Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis.
Journal: Frontiers in pharmacology
Published: June 10, 2019
Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin for first-line treatment of recurrent or metastatic nasopharyngeal carcinoma.
Journal: Oral oncology
Published: March 18, 2019
Association Between Tumor Mutation Burden (TMB) and Outcomes of Cancer Patients Treated With PD-1/PD-L1 Inhibitions: A Meta-Analysis.
Journal: Frontiers in pharmacology
Published: February 26, 2019
Last Updated: 09/26/2026